CBD of Denver Inc. (CBDD)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 24, 2025, 2:25 PM EDT
CBD of Denver Company Description
CBD of Denver Inc. engages in developing and commercializing cannabidiol (CBD) products.
It is involved in the research, development, and distribution of premium hemp extract products. The company was formerly known as Verde Media Group, Inc. and changed its name to CBD of Denver Inc. in 2018.
CBD of Denver Inc. is based in Centennial, Colorado. CBD of Denver Inc. operates as a subsidiary of Swiss Industry Ventures AG.
CBD of Denver Inc.
| Country | United States |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Paul Gurney |
Contact Details
Address: 6436 South Quebec Street Centennial, Delaware 80111 United States | |
| Phone | 720-434-3397 |
| Website | cbdofdenver.com |
Stock Details
| Ticker Symbol | CBDD |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US12482B1070 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Syed Hussain I. Abidi Ph.D. | Director and Chief Executive Officer of Verde Media Biotechnology Division |
| William F. Veve | President, Treasurer and Director |
| Ethan Weyand | Chief Financial Officer and Member of Advisory Board |
| Brent LaGrange | Head of Product Development and Secretary |